AKT1 and cancer: Further analysis showed that JWHLGJD could act on many biological processes of CRA and had an influence on the outcome of CRA through pathways in cancer, lipid and atherosclerosis, PI3K-Akt signaling pathway, and MAPK signaling pathway.